MCT

Isoform-selective Products

MCT Products

  • All (8)
  • MCT Inhibitors (8)
  • New MCT Products
Catalog No. Product Name Information Product Use Citations Product Validations
S7339 AZD3965 AZD3965 is a potent, selective and orally available monocarboxylate transporter 1 (MCT1) inhibitor with a binding affinity of 1.6 nM, 6-fold selective over MCT2. Phase 1.
J Cachexia Sarcopenia Muscle, 2023, 10.1002/jcsm.13363
Elife, 2023, 12e78546
Elife, 2023, 12e78546
S8612 α-cyano-4-hydroxycinnamic acid(α-CHCA) 4-Chloro-α-cyanocinnamic acid (α-CHCA) is a classic monocarboxylate transporters (MCT) inhibitor. α-cyano-4-hydroxycinnamate (CHC) has a 10-fold selectivity for MCT1 compared to other MCTs.
Cancer Cell Int, 2024, 24(1):5
Int J Mol Sci, 2023, 24(1)737
J Exp Clin Cancer Res, 2022, 41(1):329
S8747 BAY-8002 BAY-8002 is a novel MCT1 inhibitor and potently suppress bidirectional lactate transport. BAY-8002 significantly increases intratumor lactate levels and transiently modulates pyruvate levels.
Cell Chem Biol, 2023, 30(8):953-964.e9
Nat Commun, 2022, 13(1):5184
Cancers (Basel), 2021, 13(14)3635
S9907 Syrosingopine Syrosingopine is a dual MCT1 and MCT4 inhibitor with IC50 values of 2500nM and 40 nM in HAP1 cells, respectively.
Blood, 2021, 2649
S9929 VB124 VB124, a potent and selective MCT4 inhibitor, specifically inhibits lactate efflux/import in MDA-MB-231 cells expressing MCT4, and is used for the research of cardiac hypertrophy, heart failure, and metabolism. 
J Orthop Surg Res, 2023, 18(1):131
E1549New AZD0095 AZD0095 is a selective and orally active Monocarboxylate transporter 4 (MCT4) inhibitor with IC50 of 1.3 nM and effectively inhibits the tumor growth in NCI-H358 xenografts in combination with Cediranib.
S7919 AR-C155858 AR-C155858 is a selective monocarboxylate transporter MCT1 and MCT2 inhibitor with Ki value of 2.3 nM and 10 nM, respectively.
bioRxiv, 2024, 10.1101/2024.01.25.577208
S6732 7ACC2 7ACC2 is a potent inhibitor of mitochondrial pyruvate transport 1 (MCT1) with an IC50 value of 10 nM for lactate uptake in SiHa human cervix carcinoma cells.
S7339 AZD3965 AZD3965 is a potent, selective and orally available monocarboxylate transporter 1 (MCT1) inhibitor with a binding affinity of 1.6 nM, 6-fold selective over MCT2. Phase 1.
J Cachexia Sarcopenia Muscle, 2023, 10.1002/jcsm.13363
Elife, 2023, 12e78546
Elife, 2023, 12e78546
S8612 α-cyano-4-hydroxycinnamic acid(α-CHCA) 4-Chloro-α-cyanocinnamic acid (α-CHCA) is a classic monocarboxylate transporters (MCT) inhibitor. α-cyano-4-hydroxycinnamate (CHC) has a 10-fold selectivity for MCT1 compared to other MCTs.
Cancer Cell Int, 2024, 24(1):5
Int J Mol Sci, 2023, 24(1)737
J Exp Clin Cancer Res, 2022, 41(1):329
S8747 BAY-8002 BAY-8002 is a novel MCT1 inhibitor and potently suppress bidirectional lactate transport. BAY-8002 significantly increases intratumor lactate levels and transiently modulates pyruvate levels.
Cell Chem Biol, 2023, 30(8):953-964.e9
Nat Commun, 2022, 13(1):5184
Cancers (Basel), 2021, 13(14)3635
S9907 Syrosingopine Syrosingopine is a dual MCT1 and MCT4 inhibitor with IC50 values of 2500nM and 40 nM in HAP1 cells, respectively.
Blood, 2021, 2649
S9929 VB124 VB124, a potent and selective MCT4 inhibitor, specifically inhibits lactate efflux/import in MDA-MB-231 cells expressing MCT4, and is used for the research of cardiac hypertrophy, heart failure, and metabolism. 
J Orthop Surg Res, 2023, 18(1):131
E1549New AZD0095 AZD0095 is a selective and orally active Monocarboxylate transporter 4 (MCT4) inhibitor with IC50 of 1.3 nM and effectively inhibits the tumor growth in NCI-H358 xenografts in combination with Cediranib.
S7919 AR-C155858 AR-C155858 is a selective monocarboxylate transporter MCT1 and MCT2 inhibitor with Ki value of 2.3 nM and 10 nM, respectively.
bioRxiv, 2024, 10.1101/2024.01.25.577208
S6732 7ACC2 7ACC2 is a potent inhibitor of mitochondrial pyruvate transport 1 (MCT1) with an IC50 value of 10 nM for lactate uptake in SiHa human cervix carcinoma cells.
E1549New AZD0095 AZD0095 is a selective and orally active Monocarboxylate transporter 4 (MCT4) inhibitor with IC50 of 1.3 nM and effectively inhibits the tumor growth in NCI-H358 xenografts in combination with Cediranib.

Choose Selective MCT Inhibitors

Tags: MCT inhibitor | MCT cancer | MCT inhibitor review